Turtle Creek Wealth Advisors LLC Purchases New Position in Marsh & McLennan Companies, Inc. $MRSH

Turtle Creek Wealth Advisors LLC acquired a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report) during the 1st quarter, Holdings Channel.com reports. The fund acquired 4,998 shares of the financial services provider’s stock, valued at approximately $867,000.

A number of other institutional investors also recently modified their holdings of MRSH. Numerai GP LLC lifted its position in Marsh & McLennan Companies by 966.2% during the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after buying an additional 33,729 shares in the last quarter. Swiss Life Asset Management Ltd increased its position in Marsh & McLennan Companies by 9.5% in the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock valued at $24,960,000 after acquiring an additional 11,648 shares in the last quarter. Barclays PLC raised its stake in shares of Marsh & McLennan Companies by 41.7% in the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock worth $443,844,000 after acquiring an additional 647,987 shares during the last quarter. Sarasin & Partners LLP raised its stake in shares of Marsh & McLennan Companies by 0.9% in the fourth quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock worth $173,411,000 after acquiring an additional 8,283 shares during the last quarter. Finally, CSM Advisors LLC acquired a new position in shares of Marsh & McLennan Companies during the third quarter worth approximately $1,180,000. Institutional investors own 87.99% of the company’s stock.

Marsh & McLennan Companies Stock Down 0.2%

MRSH opened at $178.13 on Friday. The firm has a market cap of $86.05 billion, a price-to-earnings ratio of 22.27, a price-to-earnings-growth ratio of 2.60 and a beta of 0.61. Marsh & McLennan Companies, Inc. has a 52 week low of $156.60 and a 52 week high of $216.32. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11.

Marsh & McLennan Companies (NYSE:MRSHGet Free Report) last posted its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.21 by $0.08. The business had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The business’s quarterly revenue was up 7.6% on a year-over-year basis. As a group, research analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently weighed in on MRSH. Keefe, Bruyette & Woods boosted their price objective on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “market perform” rating in a research report on Friday, April 17th. Weiss Ratings lowered Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Piper Sandler lowered their target price on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research note on Tuesday, May 26th. Bank of America dropped their target price on Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating for the company in a research report on Tuesday, April 14th. Finally, JPMorgan Chase & Co. decreased their price target on Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating on the stock in a report on Thursday, April 9th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $200.19.

Read Our Latest Stock Report on Marsh & McLennan Companies

Insider Activity

In other news, CEO John Q. Doyle sold 16,656 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the sale, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $18,889,506.81. This represents a 12.48% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company’s stock.

Marsh & McLennan Companies Profile

(Free Report)

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Read More

Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report).

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MRSH)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.